Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease
- 29 March 2004
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (10) , 1065-1066
- https://doi.org/10.1038/sj.bmt.1704485
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002
- ZygomycosisInfectious Disease Clinics of North America, 2002
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 2002
- The Clinical Spectrum of Pulmonary AspergillosisChest, 2002
- Pulmonary extraction and accumulation of lipid formulations of amphotericin BCritical Care Medicine, 2000
- Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignanciesBone Marrow Transplantation, 1997
- Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?Leukemia Research, 1997